Arecor Therapeutics plc (AIM:AREC)
London · Delayed Price · Currency is GBP · Price in GBX 82.89
+2.89 (3.61%)
Oct 15, 2026, 2:45 PM GMT
Arecor Therapeutics Market Cap
Arecor Therapeutics has a market cap or net worth of 37.55 million as of October 15, 2026. It is the 30,606th most valuable company in the world and the 678th biggest in the United Kingdom. Its market cap has increased by 28.33% in one year.
Market Cap
37.55M
Enterprise Value
34.45M
Revenue
890.00K
Global Rank
Country Rank
#678 United Kingdom
PE Ratio
190.74
ChartMarket Cap Chart
Since June 3, 2021, Arecor Therapeutics's market cap has decreased from 66.99M to 37.55M, a decrease of -43.95%. That is a compound annual growth rate of -10.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 37.55M | 23.54% |
| Dec 31, 2025 | 30.39M | 9.52% |
| Dec 31, 2024 | 27.75M | -50.35% |
| Dec 29, 2023 | 55.89M | -23.94% |
| Dec 30, 2022 | 73.48M | -34.00% |
| Dec 31, 2021 | 111.34M | 66.19% |
| Jun 3, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 91.44M |
| 4basebio | 87.40M |
| Faron Pharmaceuticals Oy | 75.39M |
| Ondine Biomedical | 50.66M |
| Poolbeg Pharma | 48.86M |
| Hemogenyx Pharmaceuticals | 48.28M |
| Sareum Holdings | 38.11M |
| ImmuPharma | 23.79M |